Comparison of cyanamide and placebo in the treatment of alcohol dependence of adolescents

Alcohol and Alcoholism

Volumn 38, Issue 1, 2003, Pages 50-53

  Niederhofer, Helmut ^a   Staffen, Wolfgang ^a   Mair, Alois ^a  

^a Christian Doppler Klinik   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; BENZODIAZEPINE DERIVATIVE; BILIRUBIN; CYANAMIDE; GAMMA GLUTAMYLTRANSFERASE; NITROGEN; OPIATE DERIVATIVE; PLACEBO; SERUM ALBUMIN; TRIACYLGLYCEROL; UREA;

ADOLESCENT; ADULT; AGE; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; BEHAVIOR THERAPY; BLOOD TOXICITY; CARDIOVASCULAR DISEASE; CHRONICITY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTERVIEW; LABORATORY TEST; LIVER TOXICITY; LONG TERM CARE; LUNG DISEASE; MALE; MENTAL DISEASE; MUSCLE DISEASE; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; PATIENT CODING; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SELF REPORT; SKIN TOXICITY; TREATMENT FAILURE; UROGENITAL TRACT DISEASE;

ADOLESCENT; ALCOHOL DETERRENTS; ALCOHOLISM; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; CYANAMIDE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LONG-TERM CARE; MALE; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 0037273194     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/agg011     Document Type: Article

References (39)

1. Abajo, P., Feal, C., Sanz-Sanchez, T., Sanchez-Perez, J. and Garcia-Diez, A. (1999) Eczematous erythroderma induced by cyanamide. Contact Dermatitis 40, 160-161.
2. Ajima, M., Usuki, K., Igarashi, A., Okazaki, R., Hamano, K., Urabe, A. and Totsuka, Y. (1997) Cyanamide-induced granulocytopenia. Internal Medicine 36, 640-642.
3. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. American Psychiatric Association, Washington, DC.
4. Borg, V. (1983) Bromocriptine in the prevention of alcohol abuse. Acta Psychiatrica Scandinavica 68, 100-110.
5. Brien, J. F., Peachey, J. E., Rogers, B. J. and Loomis, C. W (1978) A study of the calcium carbimide ethanol interaction in man. European Journal of Clinical Pharmacology 14, 133-141.
6. Brien, J. F., Peachey, J. E., Loomis, C. W. and Rogers, B. J. (1979) A study of the calcium carbimide ethanol interaction in man. Clinical Pharmacology and Therapy 55, 454-463.
7. Bruguera, M., Pares, A., Heredia, D. and Rodes, J. (1987) Cyanamide hepatotoxicity. Incidence and clinico-pathological features. Liver 7, 216-222.
8. Cederbaum, I. and Dicker, E. (1985) Inhibition of peroxidatic activity of catalase toward alcohols by the aldehyde dehydrogenase inhibitor cyanamide. Toxicological Letters 29, 107-114.
9. Colom, H., Prunonosa, J., Peraire, C., Domenech, J., Azcona, O., Torrent, J. and Obach, R. (1999) Absolute bioavailability and absorption profile of cyanamide in man. Journal of Pharmacokinetic Biopharmacology 27, 421-436.
10. Deitrich, R. A., Troxell, P. A., Worth, W. and Erwin, G. V. (1976) Inhibition of aldehyde dehydrogenase in brain and liver by cyanamide. Biochemical Pharmacology 25, 2733-2737.
11. DeMaster, E. G., Kaplan, E., Shirota, F. N. and Nagasawa, H. T. (1979) Metabolic activation of cyanamide by liver mitochondria, a requirement for the inhibition of aldehyde dehydrogenase enzymes. Biochemistry, Biophysiology, Pharmacology 28, 2551-2556.
12. DeMaster, E. G., Redfern, B. and Nagasawa, H. T. (1998) Mechanisms of inhibition of aldehyde dehydrogenase by nitroxyl, the active metabolite of the alcohol deterrent agent cyanamide. Biochemical Pharmacology, 15, 2007-2015.
13. Ewing, J. A. (1984) Detecting alcoholism: the CAGE questionnaire. Journal of the American Medical Association 252, 1905-1907.
14. Feuerlein, W. (1986) Alkoholismus - Mißbrauch und Abhängigkeit, pp. 15-16. Thieme-Verlag, Stuttgart.
15. Gallimberti, L., Ferri, M., Ferrara, S. D., Fadda, F. and Gessa, G. L. (1992) Gamma-hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcoholism: Clinical and Experimental Research 16, 673-676.
16. Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62.
17. Kaplan, E. L. and Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53, 457-481.
18. Kawana, S. (1997) Drug eruption induced by cyanamide (carbimide): a clinical and histopathologic study of 7 patients. Dermatology 195, 30-34.
19. Kranzler, H. R. (2000) Pharmacotherapy of alcoholism. Gaps in knowledge and opportunities for research. Alcohol and Alcoholism 35, 537-547.
20. Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F. and Rosenheck, R. A. (2001) Naltrexone in the treatment of alcohol dependence. New England Journal of Medicine 13, 1734-1739.
21. Lehert, P. (1993) Review and discussion of the statistical analysis of controlled trials in alcoholism. Alcohol and Alcoholism 28 (Suppl. 2), 157-163.
22. Lesch, O. M., Riegler, A., Gutierrez, K., Hertling, I., Ramskogler, K., Semler, B., Zoglhami, A., Benda, N. and Walter, H. (2001) The European Acamprosate Trials: conclusions for research and therapy. Journal of Biomedical Science 8, 89-95.
23. Loomis, C. W. and Brien, J. F (1983a) Specificity of hepatic aldehyde dehydrogenase inhihition by calcium carbimide (calcium cyanamide) in the rat. Canadian Journal of Physiology and. Pharmacology 61, 430-435.
24. Loomis, C. W. and Brien, J. F. (1983b) Inhibition of hepatic aldehyde dehydrogenase in the rat by calcium carbimide (calcium cyanamide). Canadian Journal of Physiology and. Pharmacology 61, 1025-1034.
25. Mason, B. J., Ritvo, E. G., Morgan, R. O., Salvato, F. R., Goldberg, G., Welch, B. and Menkero-Atienza, E. (1994) A double-blind, placebo-controlled pilot study to evaluate the efflcacy and safety of oral nalmefene HCL for alcohol dependence. Alcoholism: Clinical and Experimental Research 18, 1162-1167.
26. Naranjo, C. A. and Kadlee, K. E. (1991) Possible pharmacological probes for predicting and preventing relapse in treated alcoholics. Alcohol and Alcoholism 26 (Suppl. 1), 523-526.
27. Obach, R., Valenti, C., Valles, B., Valles, B. M. and Domenech, J. (1986) Bioavailability of cyanamide in fasted and unfasted rats. Biopharmaceutics and Drug Disposition 7, 273-280.
28. O'Malley, S. S., Jaffe, A. J., Chang, G., Schottenfeld, R. S., Meyer, R. E. and Rounsaville, B. (1992) Naltrexone and coping skills therapy for alcohol dependence. Archives of General Psychiatry 49, 881-887.
29. m rat liver mitochondrial aldehyde dehydrogenase by cyanamide in vitro. A catalase-mediated reaction. Biochemical Pharmacology 38, 2099-2105.
30. m rat liver mitochondrial aldehyde dehydrogenase by cyanamide in vitro. Drug Metabolism and Disposition 19, 787-792.
31. Rios-Herranz, E., Carrasco-Baraja, V., Lopez-Lacomba, D. and Diez-Martin, J. L. (1992) Aplastic anemia and cyanamide. European Journal of Haematology 48, 182-197.
32. Shaw, G. K., Wafler, S., Majumdar, S. K., Alberts, J. I., Latham, G. J. and Dunn, G (1994) Tiapride in the prevention of relapse in recently detoxified alcoholics. British Journal of Psychiatry 165, 515-523.
33. Suzuki, Y., Yokoyama, A., Nakano, M., Okuyama, K., Takahashi, H., Tamai, H., Maruyama, K. and Ishii, H. (2000) Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases. Alcoholism: Clinical and Experimental Research 24, 100S-105S.
34. Tamai, H., Yokoyama, A., Okuyama, K., Takahashi, H., Maruyama, K., Suzuki, Y. and Ishii, H. (2000) Comparison of cyanamide and disulfiram in effects on liver function. Alcoholism: Clinical and Experimental Research 24, 97S-99S.
35. Torrelo, A., Soria, C., Rocamora, A., Moreno, R. and Ledo, A. (1990) Lichen planus-like eruption with esophageal involvement as a result of cyanamide. Journal of the American Academy of Dermatology 23, 1168-1169.
36. Volpicelli, J. R., Alterman, A. I., Hayashida, M. and O'Brien, C. P. (1992) Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 49, 876-880.
37. Walter, H., Ramskogler, K., Semler, B., Lesch, O. M. and Platz, W. (2001) Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials. Journal of Biomedical Science 8, 83-88.
38. Yerro, C. P., Lopez, C. P., Bernardino, A. R., Martinez, R. M., delPorto-Gomez, E. and Carmona, A. A. (2000) Relapsing pancytopenia following exposure and re-exposure to cyanamide. European Journal of Haematology 65, 414-415.
39. Yokoyama, A., Sato, S., Maruyama, K., Nakano, M., Takahashi, H., Okuyama, K., Takagi, T., Yokoyama, T. and Hayashida, M. (1995) Cyanamide-associated alcoholic liver disease: a sequential histological evaluation. Alcoholism: Clinical and Experimental Research 19, 1307-1311.